We are live on ! Find out more
HA

Havens Advisors Portfolio holdings

AUM $39.3M
1-Year Est. Return 80.07%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+80.07%
3 Year Est. Return
+460.15%
5 Year Est. Return
+1,430.14%
10 Year Est. Return
AUM
$63.3M
AUM Growth
+$8.85M
Cap. Flow
+$9.68M
Cap. Flow %
15.29%
Top 10 Hldgs %
58.21%
Holding
60
New
16
Increased
11
Reduced
4
Closed
18

Sector Composition

Rank Sector Weight
1 Technology 34.15%
2 Healthcare 20.49%
3 Industrials 14.04%
4 Communication Services 9.32%
5 Energy 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CERN
51
DELISTED
Cerner Corp
CERN
-39,300
Closed -$3.68M
OCA
52
DELISTED
Omnichannel Acquisition Corp.
OCA
-22,000
Closed -$219K
OCDX
53
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
-16,000
Closed -$299K
ZNGA
54
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-217,100
Closed -$2.01M
OTRA
55
DELISTED
OTR Acquisition Corp. Class A Common Stock
OTRA
-20,000
Closed -$204K
XENT
56
DELISTED
Intersect ENT, Inc
XENT
-109,097
Closed -$3.06M
ECOL
57
DELISTED
US Ecology, Inc.
ECOL
-30,000
Closed -$1.44M
FLOW
58
DELISTED
SPX FLOW, Inc.
FLOW
-10,000
Closed -$862K
VNE
59
DELISTED
Veoneer, Inc.
VNE
-89,000
Closed -$3.29M
REGI
60
DELISTED
Renewable Energy Group, Inc.
REGI
-20,000
Closed -$1.21M

Similar funds

Havens Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Havens Advisors held 60 positions worth $63.3M, up 16% from $54.5M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Havens Advisors deployed $9.68M of net new capital in Q2 2022, opening 16 new positions and adding to 11 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 27,000 shares worth $3.93M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 34% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Nielsen Holdings plc, an estimated $563K trimmed.

  • Havens Advisors's largest Q2 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 27,000 shares worth $3.93M.
  • Havens Advisors added most to Welbilt, Inc. in Q2 2022, an estimated $3.92M increase.
  • Havens Advisors's biggest Q2 2022 reduction was Nielsen Holdings plc, cutting an estimated $563K.
  • Havens Advisors fully exited Cerner Corp in Q2 2022, selling an estimated $3.68M.
  • Havens Advisors's ten largest holdings make up 58% of its $63.3M portfolio in Q2 2022.
  • Havens Advisors opened 16 new positions and closed 18 in Q2 2022.
  • Havens Advisors's portfolio value rose 16% quarter-over-quarter to $63.3M.

Based on Havens Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.